ZA202104166B - Sulcardine administration for treatment of acute atrial fibrillation - Google Patents
Sulcardine administration for treatment of acute atrial fibrillationInfo
- Publication number
- ZA202104166B ZA202104166B ZA2021/04166A ZA202104166A ZA202104166B ZA 202104166 B ZA202104166 B ZA 202104166B ZA 2021/04166 A ZA2021/04166 A ZA 2021/04166A ZA 202104166 A ZA202104166 A ZA 202104166A ZA 202104166 B ZA202104166 B ZA 202104166B
- Authority
- ZA
- South Africa
- Prior art keywords
- sulcardine
- administration
- treatment
- atrial fibrillation
- acute atrial
- Prior art date
Links
- SYZGIWXQGIBJGN-UHFFFAOYSA-N hbi-3000 Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NCC1=CC(CN2CCCC2)=C(O)C(CN2CCCC2)=C1 SYZGIWXQGIBJGN-UHFFFAOYSA-N 0.000 title abstract 2
- 206010003658 Atrial Fibrillation Diseases 0.000 title 1
- 230000001154 acute effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862779056P | 2018-12-13 | 2018-12-13 | |
| US201962858324P | 2019-06-06 | 2019-06-06 | |
| PCT/US2019/066003 WO2020123824A1 (en) | 2018-12-13 | 2019-12-12 | Sulcardine administration for treatment of acute atrial fibrillation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA202104166B true ZA202104166B (en) | 2023-11-29 |
Family
ID=69165588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2021/04166A ZA202104166B (en) | 2018-12-13 | 2021-06-17 | Sulcardine administration for treatment of acute atrial fibrillation |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US11364223B2 (https=) |
| EP (1) | EP3893870A1 (https=) |
| JP (1) | JP2022514537A (https=) |
| KR (1) | KR20210135990A (https=) |
| CN (1) | CN113453677A (https=) |
| AU (1) | AU2019397511B2 (https=) |
| CA (1) | CA3123078A1 (https=) |
| IL (1) | IL283931A (https=) |
| MX (1) | MX2021006933A (https=) |
| WO (1) | WO2020123824A1 (https=) |
| ZA (1) | ZA202104166B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113453677A (zh) | 2018-12-13 | 2021-09-28 | 沪亚生物国际有限责任公司 | 用于治疗急性心房颤动的舒卡定施用 |
| SG11202108160YA (en) | 2019-01-29 | 2021-08-30 | Huya Bioscience International Llc | Sulcardine salts |
| IL298907A (en) * | 2020-06-12 | 2023-02-01 | Huyabio Int Llc | Administering sulcardin for the treatment of acute atrial fibrillation |
| CN114984004B (zh) * | 2022-05-25 | 2023-09-12 | 扬州中宝药业股份有限公司 | 硫酸舒欣啶在制备抗脓毒症药物中的应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1172908C (zh) | 1999-12-10 | 2004-10-27 | 中国科学院上海药物研究所 | N-取代苄基或苯基芳香磺酰胺化合物及其用途 |
| CN1939298A (zh) | 2005-09-29 | 2007-04-04 | 中国科学院上海药物研究所 | 硫酸舒欣啶固体和靶向制剂及其制备方法 |
| JP5308333B2 (ja) | 2006-06-30 | 2013-10-09 | シグマ−タウ レア ディジージズ エスィアー | Ｌ−アスパラギナーゼｉｉを産生する組換え宿主 |
| EP2468869B1 (en) | 2007-01-31 | 2015-03-18 | Pfenex Inc. | Bacterial leader sequences for increased expression |
| EP2501380B1 (en) * | 2009-11-17 | 2016-01-27 | Huya Bioscience International LLC | Slow infusion of sulcardine and its salts |
| EP2501381B1 (en) * | 2009-11-17 | 2017-07-26 | Huya Bioscience International LLC | Treatment of atrial fibrillation |
| KR20130072201A (ko) | 2010-03-30 | 2013-07-01 | 피페넥스 인크. | 재조합 독소 단백질의 고수준 발현 |
| KR102092225B1 (ko) | 2014-04-30 | 2020-03-23 | 주식회사 엘지화학 | 고효율 분비능을 가지는 단백질 분비 인자 및 이를 포함하는 발현 벡터 |
| CN107532190B (zh) | 2014-12-01 | 2021-07-09 | 菲尼克斯公司 | 用于肽生产的融合伴侣 |
| AU2016272089B2 (en) | 2015-06-03 | 2021-02-18 | Triastek, Inc. | Dosage forms and use thereof |
| AU2017261372B2 (en) | 2016-05-05 | 2019-02-14 | Triastek, Inc. | Controlled release dosage form |
| EP3573602A4 (en) | 2017-01-26 | 2020-09-16 | Triastek, Inc. | DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES |
| CN113453677A (zh) | 2018-12-13 | 2021-09-28 | 沪亚生物国际有限责任公司 | 用于治疗急性心房颤动的舒卡定施用 |
| SG11202108160YA (en) | 2019-01-29 | 2021-08-30 | Huya Bioscience International Llc | Sulcardine salts |
-
2019
- 2019-12-12 CN CN201980092127.1A patent/CN113453677A/zh active Pending
- 2019-12-12 CA CA3123078A patent/CA3123078A1/en active Pending
- 2019-12-12 KR KR1020217021861A patent/KR20210135990A/ko not_active Ceased
- 2019-12-12 JP JP2021534215A patent/JP2022514537A/ja active Pending
- 2019-12-12 MX MX2021006933A patent/MX2021006933A/es unknown
- 2019-12-12 AU AU2019397511A patent/AU2019397511B2/en active Active
- 2019-12-12 WO PCT/US2019/066003 patent/WO2020123824A1/en not_active Ceased
- 2019-12-12 US US16/712,677 patent/US11364223B2/en active Active
- 2019-12-12 EP EP19836740.1A patent/EP3893870A1/en active Pending
-
2021
- 2021-06-13 IL IL283931A patent/IL283931A/en unknown
- 2021-06-17 ZA ZA2021/04166A patent/ZA202104166B/en unknown
-
2022
- 2022-05-23 US US17/750,944 patent/US11883380B2/en active Active
-
2023
- 2023-12-19 US US18/545,558 patent/US12357611B2/en active Active
-
2025
- 2025-06-16 US US19/239,746 patent/US20250302805A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL283931A (en) | 2021-07-29 |
| AU2019397511A1 (en) | 2021-07-22 |
| MX2021006933A (es) | 2021-09-30 |
| US20250302805A1 (en) | 2025-10-02 |
| US20240115548A1 (en) | 2024-04-11 |
| US12357611B2 (en) | 2025-07-15 |
| WO2020123824A1 (en) | 2020-06-18 |
| AU2019397511B2 (en) | 2025-08-21 |
| CN113453677A (zh) | 2021-09-28 |
| US20200188357A1 (en) | 2020-06-18 |
| JP2022514537A (ja) | 2022-02-14 |
| CA3123078A1 (en) | 2020-06-18 |
| US11883380B2 (en) | 2024-01-30 |
| EP3893870A1 (en) | 2021-10-20 |
| US20220280480A1 (en) | 2022-09-08 |
| US11364223B2 (en) | 2022-06-21 |
| KR20210135990A (ko) | 2021-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202104166B (en) | Sulcardine administration for treatment of acute atrial fibrillation | |
| ZA202308495B (en) | Pharmaceutical compositions of therapeutically active compounds | |
| PH12020500066A1 (en) | Carboxamides as modulators of sodium channels | |
| MX2025000166A (es) | Un esteroide de c21-pirazolilo disustituido con 19-nor c3,3 y metodos de uso del mismo | |
| PH12018502634A1 (en) | Topical compositions of apremilast | |
| PH12018502251A1 (en) | Formulations of an lsd1 inhibitor | |
| EP4620519A3 (en) | Methods and compositions relating to chondrisomes from blood products | |
| ZA202007149B (en) | High elasticity hyaluronan compositions and methods of use thereof | |
| PH12020551427A1 (en) | Epinephrine spray formulations | |
| MX2020004934A (es) | Composiciones y metodos para el tratamiento de los trastornos inmunitarios utilizando cepas de bacterias inmunomoduladoras de lactococcus. | |
| MX2018001842A (es) | Composiciones que incluyen extractos de ampelopsis grossedentata y albizia julibrissin y métodos para uso. | |
| MX2020003939A (es) | Inhibidores de mdm2 y metodos terapeuticos que utilizan los mismos. | |
| WO2019006005A3 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MELANOMA | |
| EP4335418A3 (en) | Compositions and methods for treating pterygium | |
| EP4299122A3 (en) | Compositions and methods for treating skin and mucous membrane diseases | |
| PH12016501788B1 (en) | Pharmaceutical compositions of therapeutically active compounds | |
| EP3687546A4 (en) | COMPOSITIONS AND METHODS FOR TREATING HEART DISEASE WITH REDIRECTED T-LYMPHOCYTE IMMUNOTHERAPIES | |
| PH12018502161A1 (en) | Methods of treatment for cholestatic and fibrotic diseases | |
| PH12020550462A1 (en) | Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same | |
| MX2019000677A (es) | Células miméticas de células b. | |
| EA201692518A2 (ru) | Способы улучшения производительности миокарда у пациентов после операции фонтена с применением композиций уденафила | |
| HK1246653A1 (zh) | 奥那司酮延长释放组合物和方法 | |
| IL278972B (en) | Methods and compositions comprising bucindolol for the treatment of atrial fibrillation | |
| PH12022553396A1 (en) | Sulcardine administration for treatment of acute atrial fibrillation | |
| EA202191612A1 (ru) | Введение сулькардина для лечения острой фибрилляции предсердий |